Pebble Biotechnology Laboratories

Pebble Biotechnology Laboratories (“PBL”) is a company based on 20+ years of pioneering NHS organ transplant research, which is now providing ex-vivo organ perfusion services to the commercial market. PBL’s specialist team will do this using the practical perfusion skills developed within the NHS, academic research, and through links with leading international research groups. The technology holds the potential to fundamentally change costs, timescales and development pathways of the complex in-vivo testing programmes that are used to generate large scale pre-clinical data for the life sciences industry.

Why we like the business

PBL offers a highly specialised skillset in a novel emerging market with potential to benefit the global med-tech and pharma markets. Furthermore, the company has a pipeline of technologies that they intend to advance, providing further benefits back to their customers, and potentially the wider patient population.